% | $
Quotes you view appear here for quick access.

NPS Pharmaceuticals, Inc. Message Board

  • dcaf7 dcaf7 Oct 3, 2013 10:03 AM Flag

    BofA initiates NPS Pharmaceuticals at Buy

    BofA initiates NPS Pharmaceuticals at Buy, sees big upside • 9:23 AM
    •BofA starts NPS Pharmaceuticals (NPSP) at Buy.
    •It looks like BofA is valuing Gattex (which is apparently seeing some off-label reimbursement of late) at around $23/share and Natpara (which may end up having higher peak sales than Gattex if you buy Leerink's thinking) at $20.
    •Adding another $2 for royalties brings the price target to $45, representing a 35% premium to Wednesday's close.
    •NPSP +1.4% premarket.

45.970.00(0.00%)Feb 20 3:59 PMEST